In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions-Reference-Cited by-同舟云学术

In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions

Published:2013-05-31 Issue:8 Volume:41 Page:1575-1583
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Reyner Eric L.,Sevidal Samantha,West Mark A.,Clouser-Roche Andrea,Freiwald Sascha,Fenner Katherine,Ullah Mohammed,Lee Caroline A.,Smith Bill J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference45 articles.

1. Bender SL, Kania, RS, and McTigue, MA (2004) inventors, Pfizer Inc., assignee. Crystal structure of human VEGFR2 kinase domain-ligand complexes and use of the atomic coordinates in drug discovery. International patent WO 2004/092217:A1. 2005 Apr 4.

2. In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation

3. Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics

4. Tyrosine Kinase Inhibitor Gefitinib Enhances Topotecan Penetration of Gliomas

5. Center for Drug Evaluation and Research (CDER) (2012a) Application Number: 202324Orig1s000, Clinical Pharmacology and Biopharmaceutics Review. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202324Orig1s000ClinPharmR.pdf, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium citrate buffer improves pazopanib solubility and absorption in gastric acid-suppressed rat model;Drug Metabolism and Pharmacokinetics;2024-04

2. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients;Acta Pharmaceutica Sinica B;2023-01

3. Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time;Pharmaceutics;2022-11-17

4. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation;Pharmacology & Therapeutics;2022-10

5. Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma;Cancers;2021-12-24